Protective immune responses against systemic candidiasis mediated by phage-displayed specific epitope of Candida albicans heat shock protein 90 in C57BL/6J mice (Q43847211)

From Wikidata

Jump to navigation Jump to search

scientific article published on 9 June 2006

Language	Label	Description	Also known as
English	Protective immune responses against systemic candidiasis mediated by phage-displayed specific epitope of Candida albicans heat shock protein 90 in C57BL/6J mice	scientific article published on 9 June 2006

Statements

scholarly article

1 reference

Europe PubMed Central

27 November 2017

Protective immune responses against systemic candidiasis mediated by phage-displayed specific epitope of Candida albicans heat shock protein 90 in C57BL/6J mice (English)

1 reference

Europe PubMed Central

27 November 2017

Candida albicans

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Guiyun Wang

1

1 reference

Europe PubMed Central

27 November 2017

Meiyan Sun

2

1 reference

Europe PubMed Central

27 November 2017

Jinbo Fang

3

1 reference

Europe PubMed Central

27 November 2017

Qiong Yang

4

1 reference

Europe PubMed Central

27 November 2017

Haibin Tong

5

1 reference

Europe PubMed Central

27 November 2017

Li Wang

6

1 reference

Europe PubMed Central

27 November 2017

language of work or name

0 references

publication date

9 June 2006

1 reference

Europe PubMed Central

27 November 2017

1 reference

Europe PubMed Central

27 November 2017

24

1 reference

Europe PubMed Central

27 November 2017

35-36

1 reference

Europe PubMed Central

27 November 2017

6065-6073

1 reference

Europe PubMed Central

27 November 2017

Antigens and immune responses in Candida albicans infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.022

7 January 2021

Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.022

7 January 2021

In vitro susceptibilities of rare Candida bloodstream isolates to ravuconazole and three comparative antifungal agents

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.022

7 January 2021

Attributable mortality of nosocomial candidemia, revisited

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.022

7 January 2021

Aspergillosis case-fatality rate: systematic review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.022

7 January 2021

Changing patterns and trends in systemic fungal infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.022

7 January 2021

Recent trends in the epidemiology of invasive mycoses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.022

7 January 2021

Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.022

7 January 2021

In vitro activities of voriconazole, posaconazole, and four licensed systemic antifungal agents against Candida species infrequently isolated from blood.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.022

7 January 2021

Immunity to Candida albicans: Th1, Th2 cells and beyond.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.022

7 January 2021

CD4(+)-T-Cell-mediated resistance to systemic murine candidiasis induced by a membrane fraction of Candida albicans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.022

7 January 2021

Role of antibodies and effect of BCG vaccination in experimental candidiasis in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.022

7 January 2021

B cell knockout mice are resistant to mucosal and systemic candidiasis of endogenous origin but susceptible to experimental systemic candidiasis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.022

7 January 2021

Innate and adaptive determinants of host susceptibility to medically important fungi

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.022

7 January 2021

Serum fluorescent antibody and immunoglobulin estimations in candidosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.022

7 January 2021

Both CD4+ and CD8+ lymphocytes reduce the severity of tissue lesions in murine systemic cadidiasis, and CD4+ cells also demonstrate strain-specific immunopathological effects.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.022

7 January 2021

Differential effects of CD4+ and CD8+ cells in acute, systemic murine candidosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.022

7 January 2021

Overview of host defenses in fungal infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.022

7 January 2021

Human recombinant antibody to HSP90: a natural partner in combination therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.022

7 January 2021

Antibodies against Candida: potential therapeutics?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.022

7 January 2021

The application of epitope mapping in the development of a new serological test for systemic candidosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.022

7 January 2021

Immunoblot analysis of the serological response in systemic candidosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.022

7 January 2021

The role of hsp90 in fungal infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.022

7 January 2021

Prophylactic vaccination with phage-displayed epitope of C. albicans elicits protective immune responses against systemic candidiasis in C57BL/6 mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.022

7 January 2021

Preliminary assessment of a human recombinant antibody fragment to hsp90 in murine invasive candidiasis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.022

7 January 2021

Phage display of peptide epitopes from HIV-1 elicits strong cytolytic responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.022

7 January 2021

Recognition of HIV-derived B and T cell epitopes displayed on filamentous phages

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.022

7 January 2021

Structural mimicry and enhanced immunogenicity of peptide epitopes displayed on filamentous bacteriophage. The V3 loop of HIV-1 gp120

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.022

7 January 2021

Role of capsid structure and membrane protein processing in determining the size and copy number of peptides displayed on the major coat protein of filamentous bacteriophage

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.022

7 January 2021

Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.022

7 January 2021

The potential of phage display virions expressing malignant tumor specific antigen MAGE-A1 epitope in murine model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.022

7 January 2021

Acquisition of lymphokine-producing phenotype by CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.022

7 January 2021

Cytokines in the generation of immune responses to, and resolution of, virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.022

7 January 2021

The instructive role of innate immunity in the acquired immune response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.022

7 January 2021

Action of natural killer cells and macrophages in cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.022

7 January 2021

Processing of filamentous bacteriophage virions in antigen-presenting cells targets both HLA class I and class II peptide loading compartments

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.022

7 January 2021

Design of specific immunogens using filamentous phage as the carrier.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.022

7 January 2021

Immunological properties of foreign peptides in multiple display on a filamentous bacteriophage

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.022

7 January 2021

Induction of hepatitis B virus-specific cytotoxic T lymphocytes response in vivo by filamentous phage display vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.022

7 January 2021

Isolation of immunodominant antigens from sera of patients with systemic candidiasis and characterization of serological response to Candida albicans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.022

7 January 2021

based on heuristic

inferred from DOI database lookup

Importance of beta2-microglobulin in murine resistance to mucosal and systemic candidiasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.022

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2006.05.022

1 reference

Europe PubMed Central

27 November 2017

1 reference

Europe PubMed Central

27 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43847211&oldid=2103845728"